Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes

Journal of Proteome Research

Volumn 6, Issue 11, 2007, Pages 4356-4362

  Sritippayawan, Suchai ^a   Chiangjong, Wararat ^a   Semangoen, Theptida ^a   Aiyasanon, Nipa ^a   Jaetanawanitch, Parnthip ^a   Sinchaikul, Supachok ^b   Chen, Shui Tein ^b,c   Vasuvattakul, Somkiat ^a   Thongboonkerd, Visith ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Dialysate; Kidney; Membranes; Peritoneal dialysis; Proteome; Renal failure; Solute clearance

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN KAPPA CHAIN; IODOBENZOIC ACID DERIVATIVE; MYRISTIC ACID; PERITONEAL DIALYSIS FLUID; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY FAILURE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ALPHA 1-ANTITRYPSIN; APOLIPOPROTEIN A-I; ASCITIC FLUID; BIOLOGICAL TRANSPORT; COMPLEMENT C4A; DIALYSIS SOLUTIONS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULINS; KIDNEY; KIDNEY FAILURE; MASS SPECTROMETRY; PERITONEAL DIALYSIS; PERITONEUM; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 36348985603     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0702969     Document Type: Article

References (22)

1. Twardowski, Z. J. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif. 1989, 7, 95-108.
2. Brimble, K. S.; Walker, M.; Margetts, P. J.; Kundhal, K. K.; Rabbat, C. G. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J. Am. Soc. Nephrol. 2006, 17, 2591-2598.
3. Davies, S. J. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int. Suppl. 2006, S76-S83.
4. Chung, S. H.; Heimburger, O.; Stenvinkel, P.; Wang, T.; Lindholm, B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Peritoneal Dial. Int. 2003, 23, 174-183.
5. Dombros, N.; Dratwa, M.; Feriani, M.; Gokal, R.; Heimburger, O.; Krediet, R.; Plum, J.; Rodrigues, A.; Selgas, R.; Struijk, D.; Verger, C. European best practice guidelines for peritoneal dialysis. 7. Adequacy of peritoneal dialysis. Nephrol. Dial. Transplant. 2005, 20 (Suppl. 9), ix24-ix27.
6. Dombros, N.; Dratwa, M.; Feriani, M.; Gokal, R.; Heimburger, O.; Krediet, R.; Plum, J.; Rodrigues, A.; Selgas, R.; Struijk, D.; Verger, C. European best practice guidelines for peritoneal dialysis. 8. Nutrition in peritoneal dialysis. Nephrol. Dial. Transplant. 2005, 20 (Suppl. 9), ix28-ix33.
7. O'Malley, R. Life's (more than) a BLAST. Biochemist 2002, 24, 21-23.
8. Thongboonkerd, V; McLeish, K. R.; Arthur, J. M.; Klein, J. B. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002, 62, 1461-1469.
9. Oh, J.; Pyo, J. H.; Jo, E. H.; Hwang, S. I.; Kang, S. C.; Jung, J. H.; Park, E. K.; Kim, S. Y.; Choi, J. Y.; Lim, J. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 2004, 4, 3485-3497.
10. Pieper, R.; Gatlin, C. L.; McGrath, A. M.; Makusky, A. J.; Mondal, M.; Seonarain, M.; Field, E.; Schatz, C. R.; Estock, M. A.; Ahmed, N.; Anderson, N. G.; Steiner, S. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
11. Kabanda, A.; Goffin, E.; Bernard, A.; Lauwerys, R.; van Ypersele, d. S. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int. 1995, 48, 1946-1952.
12. Candiano, G.; Musante, L.; Bruschi, M.; Petretto, A.; Santucci, L.; Del Boccio, P.; Pavone, B.; Perfumo, F.; Urbani, A.; Scolari, F.; Ghiggeri, G. M. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol. 2006, 17, 3139-3148.
13. Musante, L.; Candiano, G.; Petretto, A.; Bruschi, M.; Dimasi, N.; Caridi, G.; Pavone, B.; Del Boccio, P.; Galliano, M.; Urbani, A.; Scolari, F.; Vincenti, F.; Ghiggeri, G. M. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol. 2007, 18, 799-810.
14. O'Neill, G. J.; Yang, S. Y.; Dupont, B. Two HLA-linked loci controlling the fourth component of human complement. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 5165-5169.
15. Young, G. A.; Kendall, S.; Brownjohn, A. M. Complement activation during CAPD. Nephrol. Dial. Transplant. 1993, 8, 1372-1375.
16. Cohen, G. Immunoglobulin light chains in uremia. Kidney Int. Suppl. 2003, S15-S18.
17. Carrell, R. W. alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J. Clin. Invest. 1986, 78, 1427-1431.
18. Mariano, F.; Tetta, C.; Montrucchio, G.; Cavalli, P. L.; Camussi, G. Role of alpha 1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients. Kidney Int. 1992, 42, 735-742.
19. Ajees, A. A.; Anantharamaiah, G. M.; Mishra, V. K.; Hussain, M. M.; Murthy, H. M. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 2126-2131.
20. Kagan, A.; Bar-Khayim, Y.; Schafer, Z.; Fainaru, M. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. Kidney Int. 1990, 37, 980-990.
21. Querfeld, U.; LeBouef, R.; Salusky, I.; Fine, R. Lipoproteins in prediatric patients treated with CAPD/CCPD. Kidney Int. 1988, 33, 248.
22. Sezer, S.; Tutal, E.; Arat, Z.; Akcay, A.; Celik, H.; Ozdemir, F. N.; Haberal, M. Peritoneal transport status influence on atherosclerosis/ inflammation in CAPD patients. J. Renal Nutr. 2005, 15, 427-434.